Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

immunity · Mechanism Report

Can Borrelia burgdorferi IgG persist after prior exposure and still not indicate active infection?

Borrelia burgdorferi IgG can persist for years or decades after prior Lyme disease and, by itself, cannot distinguish active infection from past resolved infection.

UnsupportedNovember 7, 20266 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Borrelia burgdorferi IgG antibodies can persist after prior exposure and cannot by themselves distinguish active from past infection.

laying out figure…
1 of 2 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says a positive Borrelia burgdorferi IgG result may reflect prior exposure rather than current disease. The mechanism described is persistent antibody detection after infection has resolved, which limits the value of IgG alone for identifying active Lyme disease. Interpretation depends on the clinical picture and other appropriate testing rather than serology alone.

Verified conclusion

Prior Lyme disease can leave a durable serologic footprint. In a 69-year-old man, a positive Borrelia burgdorferi IgG result should therefore be interpreted as evidence of immunologic exposure, not as a stand-alone indicator of current infection.

Persistence and clinical evidence

  • Long-term human cohort data show persistent IgG 10–20 years after prior Lyme disease in people without evidence of active illness: 25% after earlier Lyme disease and 62% after prior Lyme arthritis.
  • CDC and IDSA/AAN/ACR guidance concur that B. burgdorferi-specific IgG—and sometimes IgM—may remain detectable for years or decades after infection has resolved or been eradicated.
  • Accordingly, serology should not be used to assess treatment response, establish cure, or infer treatment failure.

Interpretation of a positive IgG result

  • Isolated IgG positivity is compatible with remote or resolved infection, but cannot establish that current symptoms represent active Lyme disease or ongoing viable infection.
  • Interpretation requires a compatible clinical syndrome, objective findings, relevant exposure history, and use of validated two-tier serologic testing when testing is clinically indicated.
  • In the absence of an appropriate Lyme manifestation, a positive IgG result has limited ability to attribute nonspecific symptoms to active borreliosis.

Ancillary testing and practical implications

  • PCR is syndrome- and specimen-dependent: blood and CSF testing have limited sensitivity, whereas synovial-fluid PCR can assist in selected seropositive patients with suspected Lyme arthritis.
  • PCR positivity also should not be treated as independent proof of viable ongoing infection, since nucleic-acid detection may persist after treatment.

Bottom line

  • Persistent B. burgdorferi IgG after prior exposure is well established and may last decades. A positive result supports prior exposure or infection but, by itself, cannot distinguish active Lyme disease from past resolved infection.

References

  1. Laboratory Diagnostic Testing for Borrelia burgdorferi ... — cdc.gov ↗
  2. Clinical Testing and Diagnosis for Lyme Disease — cdc.gov ↗
  3. AAN/ACR/IDSA 2020 Guidelines for the Prevention, Diagnosis and ... — idsociety.org ↗
  4. Suggested Reporting Language, Interpretation and ... — cdc.gov ↗
  5. Laboratory Diagnosis of Lyme Borreliosis - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  6. Diagnosis of Lyme Borreliosis - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Unsupported6 sourcesCan antibodies alone establish active infection or catabolic illness?→Unsupported5 sourcesCan Borrelia antibodies identify an active infection?→